EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Inc. (www.kinemed.com) announced today that it is among the first funding awardees to be showcased by The Michael J. Fox Foundation Industry Partnering Program.
The Michael J. Fox Foundation (MJFF) sponsored KineMed’s recently completed pathway-based biomarker study of neuronal function, which measures differences in brain neuronal transport function in Parkinson’s patients compared to healthy controls. Using KineMed’s proprietary proteome dynamics technology, this research showed, for the first time, abnormalities in biochemical pathways in neurons in the living brain that appear to be associated with the pathogenesis and disease progression of Parkinson’s disease.
